SCHEMBL23657161

SCHEMBL23657161

CCOC(=O)/C=C/C(=O)N(C)c1nccs1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.55
HTT P42858 2/20 0.55
LMNA P02545 2/20 0.55
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
ALDH1A1 P00352 4/20 0.42
PKM P14618 2/20 0.42
HCAR2 Q8TDS4 1/20 0.39
FFAR2 O15552 1/20 0.38
TRPM8 Q7Z2W7 2/20 0.37
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.36
NR3C1 P04150 1/20 0.36
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
MDM2 Q00987 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19974178 0.80 FFAR2 (0.43) MAPTHTTLMNAMEN1KMT2A
SCHEMBL19974179 0.80 FFAR2 (0.43) MAPTHTTLMNAMEN1KMT2A
SCHEMBL19981466 0.80 FFAR2 (0.43) MAPTHTTLMNAMEN1KMT2A
SCHEMBL19981402 0.77 MAPT (0.46) MAPTHTTLMNAMEN1KMT2A
SCHEMBL19981401 0.75 MAPT (0.44) MAPTHTTLMNAMEN1KMT2A
SCHEMBL13545685 0.75 FFAR2 (0.46) MAPTHTTLMNAMEN1KMT2A
SCHEMBL19981415 0.74 MAPT (0.43) MAPTHTTLMNAMEN1KMT2A
SCHEMBL19981403 0.74 LMNA (0.43) MAPTHTTLMNAMEN1KMT2A
SCHEMBL23647319 0.73 HCAR2 (0.42) MAPTHTTLMNAMEN1KMT2A
SCHEMBL8276819 0.73 MAPT (0.58) MAPTHTTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512602-B1 INHIBITORS OF HEAT SHOCK FACTORS (HSF) AND USES THEREOF HSF PHARMACEUTICALS (CH) 2024-03-27 EP disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 MAPT 2930/4885HTT 1981/4885LMNA 3549/4885
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 MAPT 2930/4885HTT 1981/4885LMNA 3549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.